Target intelligence / Profile preview

Centromere protein M (CENPM)

Target
CENPM
Molecular classification
Structural centromere protein, Constitutive centromere-associated network protein, Pseudo GTPase (structural homology, lacks GTPase activity)
01

Overview

Centromere protein M (CENPM) is a structural inner kinetochore protein that is essential for chromosome segregation during cell division[2][6]. It is a core component of the constitutive centromere-associated network and participates in the assembly and stability of the HIKM complex (with CENP-H, -I, and -K), required for kinetochore function[1][2]. CENPM is structurally related to small GTPases but lacks nucleotide-binding activity[1][2]. Alternative transcription leads to a variant expressed in B-lymphoid cells, with potential immune-regulatory roles[4]. Overexpression of CENPM is implicated in several malignancies and is associated with poor clinical prognosis, supporting its potential as a prognostic biomarker in cancer[3]. As of now, specific drugs targeting CENPM are not clinically established, but its biological significance in mitosis and oncogenesis supports ongoing research interest in its mechanistic and therapeutic potential[3].

Other names
CENPMC22orf18ICEN39PANE1CENP-MInterphase centromere complex protein 39Proliferation-associated nuclear element protein 1
02

Mechanism of action

Not established as a direct therapeutic target for small molecules or biologics; proposed mechanisms in cancer models include modulation of cell proliferation and apoptosis via regulation of the AKT/mTOR signaling pathway

03

Biological functions

Kinetochore assembly and stabilityChromosome segregation during cell division (mitosis and meiosis)Maintenance of centromere identityRegulation of cell proliferation and apoptosisImmune response (alternative transcript in B-lymphoid cells)
04

Disease associations

Cancer (notably lung adenocarcinoma, hepatocellular carcinoma, pancreatic cancer, melanoma, bladder cancer)Diffuse large B-cell lymphomaChromosome 17p13.3 centromeric duplication syndrome
05

Safety considerations

Targeting CENPM could potentially disrupt normal chromosome segregation, posing risks for genomic instability/aneuploidy and limiting therapeutic window in normal dividing cells
06

Biomarkers

Overexpression in tumors such as lung adenocarcinoma, hepatocellular carcinoma, pancreatic cancer, and others may serve as a prognostic/diagnostic biomarkerProtein and mRNA levels measurable in tissue and cell lines

Beyond the preview

Go deeper on Centromere protein M (CENPM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centromere protein M (CENPM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call